• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外循环期间活化凝血时间与血浆肝素之间缺乏相关性。

Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass.

作者信息

Culliford A T, Gitel S N, Starr N, Thomas S T, Baumann F G, Wessler S, Spencer F C

出版信息

Ann Surg. 1981 Jan;193(1):105-11. doi: 10.1097/00000658-198101000-00017.

DOI:10.1097/00000658-198101000-00017
PMID:6970015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1345010/
Abstract

The activated clotting time (ACT) with a Hemochron system for determining heparin requirements during cardiopulmonary bypass surgery, (CPB) accompanied by hemodilution and hypothermia was evaluated using plasma heparin levels as a standard. In 28 patients who were administered a standard heparin regimen (300 units/kg prebypass, 8000 units in the pump prime and 100 units/kg hourly during CPB) mean prebypass plasma heparin was 4 units/ml, and ACT was 493 seconds. During CPB mean plasma heparin decreased significantly (p < 0.001) to 3.1 units/ml, whereas mean ACT increased significantly (p < 0.001) to 674 seconds. The mean protamine requirement predicted from ACT was significantly higher (43%) than predicted from plasma heparin levels or actual protamine administered. The ACT neither accurately reflected plasma heparin during CPB nor predicted protamine requirements. The fixed-dose regimen employed, however, prevented both intraoperative thrombosis, assessed clinically in all patients, and clotting on six arterial line filters, as determined by scanning EM, despite wide variations in ACT and plasma heparin levels during surgery.

摘要

以血浆肝素水平为标准,对使用Hemochron系统测定体外循环手术(CPB)期间肝素需求量时的活化凝血时间(ACT)进行了评估,该手术伴有血液稀释和低温。在28例接受标准肝素方案(体外循环前300单位/千克,预充液中8000单位,体外循环期间每小时100单位/千克)的患者中,体外循环前血浆肝素平均水平为4单位/毫升,ACT为493秒。体外循环期间,血浆肝素平均水平显著降低(p < 0.001)至3.1单位/毫升,而ACT平均显著升高(p < 0.001)至674秒。根据ACT预测的鱼精蛋白平均需求量显著高于根据血浆肝素水平或实际给予的鱼精蛋白预测的需求量(43%)。ACT在体外循环期间既不能准确反映血浆肝素水平,也不能预测鱼精蛋白需求量。然而,尽管手术期间ACT和血浆肝素水平存在很大差异,但所采用的固定剂量方案可防止所有患者临床评估的术中血栓形成以及扫描电镜测定的六个动脉管路滤器上的凝血。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/979f/1345010/ac5eca6655c2/annsurg00215-0121-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/979f/1345010/ac5eca6655c2/annsurg00215-0121-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/979f/1345010/ac5eca6655c2/annsurg00215-0121-a.jpg

相似文献

1
Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass.体外循环期间活化凝血时间与血浆肝素之间缺乏相关性。
Ann Surg. 1981 Jan;193(1):105-11. doi: 10.1097/00000658-198101000-00017.
2
The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.活化凝血时间在体外循环肝素给药及中和中的作用。
J Thorac Cardiovasc Surg. 1983 Feb;85(2):174-85.
3
Correlation of ACT as measured with three commercially available devices with circulating heparin level during cardiac surgery.心脏手术期间使用三种市售设备测量的活化凝血时间(ACT)与循环肝素水平的相关性。
J Extra Corpor Technol. 1995 Dec;27(4):197-200.
4
The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation.用于体外循环期间肝素化监测的血浆补充改良活化凝血时间:一项初步研究。
Anesth Analg. 2002 Jul;95(1):26-30, table of contents. doi: 10.1097/00000539-200207000-00004.
5
Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.行体外循环的婴幼儿的活化凝血时间值与肝素浓度测量值之间的相关性。
Anesth Analg. 2010 Jul;111(1):173-9. doi: 10.1213/ANE.0b013e3181e13470. Epub 2010 Jun 2.
6
Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass.激活凝血时间系统在精度和偏差方面存在差异,在体外循环期间遵循肝素管理方案时不可互换。
J Clin Monit Comput. 2002 Jul;17(5):287-92. doi: 10.1023/a:1021298103264.
7
Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.体外循环期间应用活化凝血时间控制肝素和鱼精蛋白治疗的临床经验。
J Thorac Cardiovasc Surg. 1980 Jan;79(1):97-102.
8
The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.肝素浓度及活化凝血时间监测对血液保护的影响。一项针对心脏手术患者的前瞻性随机评估。
J Thorac Cardiovasc Surg. 1995 Jul;110(1):46-54. doi: 10.1016/S0022-5223(05)80008-X.
9
Blood transfusion requirements in coronary artery surgery with and without the activated clotting time (ACT) technique.采用和不采用活化凝血时间(ACT)技术的冠状动脉手术中的输血需求。
Klin Wochenschr. 1985 Mar 15;63(6):252-6. doi: 10.1007/BF01731470.
10
Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.监测肝素与抑肽酶联合应用时的活化凝血时间:使用Sonoclot对一种新型抑肽酶不敏感检测方法的体内评估
Eur J Cardiothorac Surg. 2006 Aug;30(2):278-84. doi: 10.1016/j.ejcts.2006.05.016. Epub 2006 Jul 7.

引用本文的文献

1
Comparison of Blood Concentration and Weight-Based Heparin and Protamine Dosing Strategies for Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis.体外循环中基于血药浓度和体重的肝素与鱼精蛋白给药策略的比较:一项系统评价和荟萃分析
Cureus. 2024 Feb 13;16(2):e54144. doi: 10.7759/cureus.54144. eCollection 2024 Feb.
2
Heparin Resistance During Cardiopulmonary Bypass in Adult Cardiac Surgery.成人心脏手术体外循环期间的肝素抵抗。
J Cardiothorac Vasc Anesth. 2022 Nov;36(11):4150-4160. doi: 10.1053/j.jvca.2022.06.021. Epub 2022 Jun 24.
3
Can We Rely on the Activated Clotting Time to Measure Heparin Anticoagulation? A Clinical Evaluation of Two ACT Monitors.

本文引用的文献

1
Activated coagulation time of whole blood.
JAMA. 1966 May 2;196(5):436-40.
2
Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time.
Am J Clin Pathol. 1973 Sep;60(3):323-9. doi: 10.1093/ajcp/60.3.323.
3
Plasma heparin: a unique, practical, submicrogram-sensitive assay.血浆肝素:一种独特、实用、对亚微克敏感的检测方法。
J Lab Clin Med. 1973 Feb;81(2):298-310.
4
我们能否依靠活化凝血时间来测定肝素抗凝效果?两种活化凝血时间监测仪的临床评估。
J Extra Corpor Technol. 2020 Sep;52(3):212-217. doi: 10.1182/ject-2000005.
4
Flow Rate and Raspberry Pi-based Paper Microfluidic Blood Coagulation Assay Device.流速与基于树莓派的纸质微流控血液凝固检测装置
IEEE Sens J. 2019 Jul 1;19(13):4743-4751. doi: 10.1109/jsen.2019.2902065. Epub 2019 Feb 27.
5
In vitro and in vivo effects of hemodilution on kaolin-based activated clotting time predicted heparin requirement using a heparin dose-response technique.采用肝素剂量反应技术,体外和体内血液稀释对基于高岭土的活化凝血时间的影响预测肝素需求量。
J Anesth. 2016 Dec;30(6):923-928. doi: 10.1007/s00540-016-2227-9. Epub 2016 Aug 8.
6
Predictive value of rotational thromboelastometry during cardiopulmonary bypass for thrombocytopenia and hypofibrinogenemia after weaning of cardiopulmonary bypass.体外循环期间旋转血栓弹力图对体外循环撤机后血小板减少症和低纤维蛋白原血症的预测价值
Korean J Anesthesiol. 2015 Jun;68(3):241-8. doi: 10.4097/kjae.2015.68.3.241. Epub 2015 May 28.
7
The effect of cyanosis on active clotting time during diagnostic catheterization.诊断性心导管插入术中发绀对活化凝血时间的影响。
J Cardiovasc Thorac Res. 2012;4(2):49-52. doi: 10.5681/jcvtr.2012.012. Epub 2012 Sep 8.
8
Suspected intraoperative formation of left atrial thrombus in a patient with atrial fibrillation receiving bridging anticoagulation therapy.
J Anesth. 2014 Feb;28(1):112-5. doi: 10.1007/s00540-013-1664-y. Epub 2013 Jun 28.
9
Comparison of point-of-care activated clotting time systems utilized in a single pediatric institution.在一家儿科机构中使用的即时护理活化凝血时间系统的比较。
J Extra Corpor Technol. 2012 Mar;44(1):15-20.
10
Back to the stacks--looking at classic papers related to the current practice of cardiopulmonary bypass.回到文献堆中——看看与当前体外循环实践相关的经典论文。
J Extra Corpor Technol. 2010 Dec;42(4):265-7.
De-heparinisation of blood after cardiopulmonary bypass.
体外循环后血液的去肝素化
Lancet. 1966 Mar 12;1(7437):563-5. doi: 10.1016/s0140-6736(66)90759-8.
5
A simple rapid polychrome stain for epoxy-embedded tissue.一种用于环氧树脂包埋组织的简单快速多色染色法。
Stain Technol. 1973 Sep;48(5):223-7. doi: 10.3109/10520297309116628.
6
Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.体外循环期间的肝素治疗。II. 使用剂量反应曲线个体化肝素和鱼精蛋白剂量。
J Thorac Cardiovasc Surg. 1975 May;69(5):685-9.
7
Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.体外循环期间的肝素治疗。I. 现有肝素方案中存在的问题。
J Thorac Cardiovasc Surg. 1975 May;69(5):674-84.
8
Progress report: the activated coagulation time of whole blood (ACT).进展报告:全血活化凝血时间(ACT)
Am J Clin Pathol. 1976 Nov;66(5):899-904. doi: 10.1093/ajcp/66.5.899.
9
Evaluation of the activated clotting time to control heparin andprotamine dosage in open-heart surgery.
J Thorac Cardiovasc Surg. 1978 May;75(5):790-2.
10
Evaluation of the activated whole blood clotting time (ACT) in vitro.体外活化全血凝固时间(ACT)的评估。
Scand J Haematol. 1979 Sep;23(3):239-44. doi: 10.1111/j.1600-0609.1979.tb02698.x.